somatostatin-4 agonists and somatostatin-4/2 dual-agonists (Crinetics Pharmaceuticals)

N/A

Report date: 2025/01/26 15:43:26
NME

Base Information

Drug Namesomatostatin-4 agonists and somatostatin-4/2 dual-agonists (Crinetics Pharmaceuticals)
Drug Alias Namesst4 agonists and sst4/2 dual-agonists (Crinetics Pharmaceuticals)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionSomatostatin receptor 4 agonistsSomatostatin receptor 2 agonists
TargetsSomatostatin receptor 2Somatostatin receptor 4
Therapy Area/IndicationsNeuralgia
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesCrinetics Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesCrinetics Pharmaceuticals Inc
Inactive CompaniesN/A
Active IndicationsNeuralgia
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A